Data gathered: November 22
Alternative Data for Revvity
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 191 | Sign up | Sign up | Sign up |
| Sentiment | 84 | Sign up | Sign up | Sign up |
| Webpage traffic | 239,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 64 | Sign up | Sign up | Sign up |
| Patents | 319 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 147,902 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,639 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 695 | Sign up | Sign up | Sign up |
| Twitter Followers | 45,887 | Sign up | Sign up | Sign up |
| Twitter Mentions | 6 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 440 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 37 | Sign up | Sign up | Sign up |
| Linkedin Employees | 3,064 | Sign up | Sign up | Sign up |
About Revvity
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families.
| Price | $112.39 |
| Target Price | Sign up |
| Volume | 579,960 |
| Market Cap | $13.6B |
| Year Range | $99.26 - $127.68 |
| Dividend Yield | 0.25% |
| PE Ratio | 53.27 |
| Analyst Rating | 67% buy |
| Industry | Health Care Services |
In the news
Revvity : Investor Day 2024 PresentationNovember 20 - Finnhub |
|
 |
CIBC Asset Management Inc Has $2.30 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY)November 20 - ETF Daily News |
 |
Revvity Broadens Relationship with Genomics England to Advance Genomics in the UKNovember 19 - Yahoo |
 |
Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single CellsNovember 18 - Yahoo |
 |
Revvity to Present at 7th Annual Evercore ISI HealthCONx ConferenceNovember 18 - Yahoo |
 |
Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent TransformationNovember 17 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 684M | 626M | 58M | 94M | 188M | 1.280 |
| Q2 '24 | 692M | 648M | 43M | 55M | 185M | 1.220 |
| Q1 '24 | 650M | 647M | 3.7M | 26M | 147M | 0.980 |
| Q4 '23 | 767M | -456M | 1.22B | 79M | 167M | 1.250 |
| Q3 '23 | 645M | 639M | 5.9M | 9.5M | 144M | 1.180 |
Insider Transactions View All
| Vohra Tajinder S filed to sell 19,652 shares at $122.6. October 10 '24 |
| Vohra Tajinder S filed to sell 19,672 shares at $121.7. October 10 '24 |
| Vohra Tajinder S filed to sell 21,806 shares at $123. October 9 '24 |
| Vohra Tajinder S filed to sell 22,299 shares at $122.5. October 9 '24 |
| Vohra Tajinder S filed to sell 23,960 shares at $123.1. October 9 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
May 6, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
Read more about Revvity (RVTY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Revvity?
The Market Cap of Revvity is $13.6B.
What is Revvity's PE Ratio?
As of today, Revvity's PE (Price to Earnings) ratio is 53.27.
What is the current stock price of Revvity?
Currently, the price of one share of Revvity stock is $112.39.
How can I analyze the RVTY stock price chart for investment decisions?
The RVTY stock price chart above provides a comprehensive visual representation of Revvity's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Revvity shares. Our platform offers an up-to-date RVTY stock price chart, along with technical data analysis and alternative data insights.
Does RVTY offer dividends to its shareholders?
Yes, Revvity (RVTY) offers dividends to its shareholders, with a dividend yield of 0.25%. This dividend yield represents Revvity's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Revvity in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Revvity?
Some of the similar stocks of Revvity are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.